Meng et al. demonstrated that morin hydrate represses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells (HUVECs) and ameliorates atherosclerosis formation through the inhibition of PI-3K/AKT/NFκB pathway 26. The gene discussed is NFKB1; the disease is atherosclerosis.